arznei-telegramm Logo a-t Kurzlogo
    ❮ a-t 11/2023 a-t ❯
    This is a translation of the table of contents. One article of each issue is translated and freely available.
    table of contents
    NEW ON THE MARKET

    Nirsevimab (BEYFORTUS) for the prevention of respiratory syncytial virus infections in babies

    THERAPY FROM A CRITICAL VIEWPOINT

    Increased risk of diabetes and cataract with rosuvastatin (CRESTOR, generics)

    Myopia: new data on low-dose atropine eye drops for the treatment in children

    BEWARE MISINFORMATION

    Once again: COIMBRA protocol in multiple sclerosis

    Torasemide: flawed meta-analysis claims advantages
    free

    a-t READERS QUESTIONS AND COMMENTS

    Lactoferrin: balanced diet against iron deficiency anaemia?

    IN BRIEF

    SELECT trial on semaglutide (WEGOVY) published

    Payments by pharmaceutical companies to physicians can make patient care worse or more expensive

    SIDE EFFECTS

    Risks of the recreational drug nitrous oxide

    arznei-telegramm

    Independent drug information – in English

    Concise, critical evaluations of drugs and medical devices for evidence-based therapy and patient advice on benefits and risks – independent, ad-free and funded exclusively by subscriptions.

    Browse free articles

    Wir schätzen Ihr Feedback

    Nehmen Sie an unserer Umfrage teil!